A systematic analysis of the particle irradiation data ensemble in the key of the microdosimetric kinetic model: Should clonogenic data be used for clinical relative biological effectiveness?

Helium therapy Ion therapy Microdosimetric kinetic model Proton therapy Radiobiology Relative biological effectiveness

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
08 2023
Historique:
received: 01 12 2022
revised: 20 05 2023
accepted: 31 05 2023
pmc-release: 01 08 2024
medline: 17 7 2023
pubmed: 11 6 2023
entrez: 10 6 2023
Statut: ppublish

Résumé

To perform a systematic analysis of the Particle Irradiation Data Ensemble (PIDE) database for clonogenic survival assays in the context of the Microdosimetric Kinetic Model (MKM). Our study used data from the PIDE database containing data on various cell lines and radiation types. Two main parameters of the MKM were determined experiment-wise: the domain radius, which accounts for the increase of the linear parameter as a function of LET or lineal energy, and the nucleus radius, which accounts for the overkilling effect at LET high enough. We used experiments with LET less and more than 75 keV/μm to determine domain and nucleus radius, respectively. Experiments with cells in asynchronous phase of the cell cycle and monoenergetic beams were considered, and data from 294 out of 461 available experiments with protons, alpha, and carbon beams were used. Domain and nucleus radii were determined for 32 cell lines as the median among cell-specific experiments after filtering experiments using protons, α-particles, and carbon ions, including 28 human cells and 12 rodent cells. The median values found for domain radii were 380 nm for normal human cells, 390 nm for tumor human cells, 295 nm for normal rodent cells, and 525 nm for tumor rodent cells (only one experiment with rodent tumor cells) with large variability across cell lines and across experiments on each cell line. Large inter-experiment variabilities were found for the same cell lines, based on enormous experimental uncertainties and different experimental conditions. Our analysis raises questions about how convenient is to use clonogenic data to feed RBE models to be utilized in the clinical practice in particle therapy.

Identifiants

pubmed: 37301260
pii: S0167-8140(23)00268-2
doi: 10.1016/j.radonc.2023.109730
pmc: PMC10528084
mid: NIHMS1909219
pii:
doi:

Substances chimiques

Protons 0
Carbon 7440-44-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109730

Subventions

Organisme : NCI NIH HHS
ID : K99 CA267560
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Int J Mol Sci. 2022 Oct 18;23(20):
pubmed: 36293348
J Radiat Res. 2013 May;54(3):494-514
pubmed: 23266948
Phys Med Biol. 2020 Apr 02;65(7):075011
pubmed: 32023557
Int J Radiat Biol. 1996 Jun;69(6):739-55
pubmed: 8691026
Med Phys. 2019 Sep;46(9):4184-4192
pubmed: 31169910
JAMA Oncol. 2016 Dec 1;2(12):1539-1540
pubmed: 27541302
Phys Med Biol. 2021 Oct 11;66(20):
pubmed: 34560678
Radiat Prot Dosimetry. 2006;122(1-4):367-8
pubmed: 17251253
Med Phys. 2020 Feb;47(2):745-752
pubmed: 31758864
Radiat Res. 1981 Jul;87(1):59-78
pubmed: 7255673
Phys Med Biol. 2015 Nov 7;60(21):8399-416
pubmed: 26459756
Phys Med Biol. 2008 Jan 7;53(1):37-59
pubmed: 18182686
Radiat Res. 2020 Oct 2;194(4):403-410
pubmed: 33045091
Technol Cancer Res Treat. 2003 Oct;2(5):377-87
pubmed: 14529303
Phys Med Biol. 2010 Nov 21;55(22):6721-37
pubmed: 21030747
Acta Oncol. 2013 Apr;52(3):580-8
pubmed: 22909391
Phys Med Biol. 2021 Jul 30;66(15):
pubmed: 34280910
Radiat Res. 2009 Sep;172(3):394-402
pubmed: 19708788
Med Phys. 2018 Jun 14;:
pubmed: 29901835
Med Phys. 2019 Mar;46(3):e53-e78
pubmed: 30661238
Phys Med Biol. 2014 Nov 21;59(22):R419-72
pubmed: 25361443
Phys Med. 2015 Dec;31(8):861-874
pubmed: 26653251
Phys Med Biol. 2012 Mar 7;57(5):1159-72
pubmed: 22330133
J ICRU. 2005 Jun;5(1):iii-viii
pubmed: 24170853
Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):228-235
pubmed: 28068231
Sci Rep. 2016 Sep 14;6:33290
pubmed: 27624453
Med Phys. 2020 Jun;47(6):2495-2505
pubmed: 32124463
Phys Med Biol. 2015 Apr 21;60(8):3271-86
pubmed: 25826534
Med Phys. 2010 Sep;37(9):4692-708
pubmed: 20964188
Cancers (Basel). 2018 Mar 06;10(3):
pubmed: 29509684
Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Apr;49(4):611-20
pubmed: 3485603
Phys Med. 2021 Jan;81:69-76
pubmed: 33440283
Int J Radiat Biol. 1998 Oct;74(4):501-9
pubmed: 9798961
Int J Radiat Biol. 1994 Nov;66(5):537-42
pubmed: 7983442
Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):316-324
pubmed: 30731186
Radiat Res. 2006 Oct;166(4):629-38
pubmed: 17007551
Radiat Res. 2003 Jul;160(1):61-9
pubmed: 12816524
J Radiat Res. 2011;52(1):75-81
pubmed: 21160135
Med Phys. 2019 Sep;46(9):4204-4214
pubmed: 31228264
Sci Rep. 2017 Sep 7;7(1):10790
pubmed: 28883414
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):557-68
pubmed: 26460998
Med Phys. 2018 Jul;45(7):3404-3416
pubmed: 29788552
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):779-791
pubmed: 32504659
Radiat Prot Dosimetry. 2011 Feb;143(2-4):491-6
pubmed: 21148591
Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Dec;52(6):893-902
pubmed: 3500930
Radiat Prot Dosimetry. 2006;122(1-4):475-7
pubmed: 17164283
Radiat Res. 2009 Dec;172(6):761-76
pubmed: 19929423
Br J Radiol. 2020 Mar;93(1107):20190334
pubmed: 31738081
Med Phys. 2022 Jan;49(1):714-726
pubmed: 34766635
Phys Med Biol. 2017 Feb 7;62(3):890-908
pubmed: 28072575

Auteurs

Daniel Suárez-García (D)

Departamento de Física Nuclear, Atómica y Molecular, Universidad de Sevilla, Sevilla, Spain.

Miguel Antonio Cortés-Giraldo (MA)

Departamento de Física Nuclear, Atómica y Molecular, Universidad de Sevilla, Sevilla, Spain.

Alejandro Bertolet (A)

Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: abertoletreina@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH